George Adams., Director at Sernova, holds 1.64M shares in VentriPoint Diagnostics (Ticker: TSE:VPT), holds 644.50K shares in Sernova (Ticker: TSE:SVA), holds 151.97K shares in ProMIS Neurosciences (Ticker: PMN). Most recently, George Adams. Bought ― shares of VentriPoint Diagnostics on May 08, 2021 for an estimated value of 17.80K.